Clinical pathways follow international standards with Italian gatekeeping characteristics#

Italian gender clinics formally adhere to WPATH Standards of Care (SOC8) and Endocrine Society guidelines, though the system maintains more gatekeeping requirements than the informed consent models increasingly adopted elsewhere in Europe (Coleman et al., 2022; Hembree et al., 2017). Entry into care begins with a mandatory psychological or psychiatric evaluation—there is no direct pathway to hormones without this assessment.

Assessment tools used in gender-clinic evaluations can include the Body Uneasiness Test (BUT-A), Symptom Checklist-90 Revised (SCL-90R), Bem Sex Role Inventory, and structured clinical interviews (SCID I and II) for evaluating psychiatric comorbidities. Evaluators assess gender identity history, capacity for informed consent, social support systems, and screen for conditions that might affect treatment decisions. The assessment phase has no fixed duration—sessions are individualized—but adolescents face a minimum six-month observation period before accessing puberty blockers.

The diagnostic framework has evolved with ICD-11's reclassification of "Gender Incongruence" from mental disorders to "Conditions Related to Sexual Health" (World Health Organization, 2019), though clinical practice still references DSM-5 Gender Dysphoria criteria, particularly for court documentation (American Psychiatric Association, 2013). Research from the Florence gender clinic found 62.7% of patients present with psychiatric comorbidities (Fisher et al., 2018), underscoring why comprehensive evaluation remains standard practice despite advocacy for depathologization.

Hormone therapy protocols and monitoring requirements#

Feminizing hormone regimens typically combine estradiol (oral or transdermal) with anti-androgens, most commonly cyproterone acetate at 50mg daily—the European standard unavailable in the United States (Hembree et al., 2017). Target serum estradiol levels range from 100-200 pg/mL with testosterone suppression below 50 ng/dL. Transdermal estrogen is preferred for patients over 45 or those with venous thromboembolism history (Seal, 2017). Masculinizing therapy uses testosterone (intramuscular injections or transdermal gel) targeting 300-1000 ng/dL (Hembree et al., 2017).

Monitoring requires blood tests every three months during the first year, then every 6-12 months after stabilization (T'Sjoen et al., 2020). Parameters tracked include hormone levels, complete blood count, comprehensive metabolic panel, lipid profile, HbA1c, liver function (especially critical with cyproterone), and prolactin for estrogen therapy patients. Bone mineral density screening applies to patients with osteoporosis risk or consistently low sex hormone levels.

Since 2020, hormone therapy has been fully covered by the SSN with no copay required at specialized centers (Agenzia Italiana del Farmaco, 2020). The AIFA (Italian Medicines Agency) approved triptorelin (GnRH agonist) for off-label use in adolescents with gender incongruence in March 2019 (Agenzia Italiana del Farmaco, 2019), though access has become complicated by recent political scrutiny.

Surgical techniques available and their outcomes#

Italian centers offer gender-affirming surgeries through the SSN, with regional variation in capabilities. For trans women, penile-scrotal inversion vaginoplasty is a primary technique and can include clitoroplasty using glans tissue. Colon vaginoplasty, using a sigmoid colon section, is available for patients with insufficient penile tissue—this self-lubricating option involves a 7-hour procedure with a 58% complication rate (mostly minor, including introital stricture and excessive discharge in 28.6% of cases) (Rossi Neto et al., 2018). Advanced techniques like peritoneal pull-through vaginoplasty (PPV) are not routinely available through Italian public healthcare.

For trans men, options include metoidioplasty (1-2 surgical stages, creating a small neophallus from hormone-enlarged clitoris), suprapubic pedicled phalloplasty using abdominal tissue (the Pryor technique, approximately 2 hours, creating a 12-14 cm phallus), and radial forearm free flap phalloplasty (better for urethral lengthening, 5% serious vascular complication risk) (Monstrey et al., 2009). A 2008-2018 Italian multicenter study of suprapubic phalloplasty (n=34) found 89% full satisfaction, 83% would recommend, and 66% achieved orgasm with penetration (Bettocchi et al., 2020).

Phalloplasty complications remain clinically important, but rates vary by technique, staging, follow-up, and the definitions used in individual studies; discuss a surgeon's own outcomes and revision pathway rather than relying on a pooled figure attached to an unrelated facial-feminization study. Vaginoplasty complications occur in up to 70% of cases, though most are minor and don't affect long-term outcomes; patient satisfaction reaches approximately 93% (Horbach et al., 2015).

Procedures not covered by SSN include facial feminization surgery, voice feminization surgery (phonosurgery), hair removal/electrolysis, hair transplantation, and breast augmentation (though mastectomy for trans men is covered). These "cosmetic" exclusions force patients to pay privately or travel abroad.

Fertility preservation remains a significant gap#

Fertility preservation options theoretically available include sperm cryopreservation, oocyte cryopreservation, embryo freezing, and experimental ovarian/testicular tissue cryopreservation (Ethics Committee of the American Society for Reproductive Medicine, 2015). However, these services are not routinely covered by SSN for transgender individuals—public fertility preservation currently serves primarily oncological patients.

Timing matters: preservation ideally occurs before hormone therapy begins, as achieving viable gametes after HRT initiation may require 3+ months off hormones (Hembree et al., 2017). Preliminary research suggests ovarian tissue may remain viable even after prolonged testosterone use (Armuand et al., 2017).

Critically, Italian Law 40/2004 restricts assisted reproduction to married or cohabiting heterosexual couples, excluding single individuals and same-sex couples from using preserved gametes through Italian fertility services (Legge 19 febbraio 2004, n. 40). Law 4 November 2024, no. 169 makes an Italian citizen punishable under Italian law for Article 12(6) surrogacy conduct committed abroad by an Italian citizen; this adds a serious legal constraint to some paths involving surrogacy, but its scope should not be stated as applying to every person who seeks surrogacy abroad (Legge 4 novembre 2024, n. 169).

Wait times and access barriers vary dramatically by region#

The TGEU Trans Health Map 2024 places Italy among European countries with the longest trans-specific healthcare wait times, alongside Sweden, Belgium, the Netherlands, and Finland (Transgender Europe, 2024). Initial appointments at dedicated centers require 1-3 years of waiting, with surgical procedures adding additional years beyond that.

Current situation at major centers#

CIDIGEM Turin (Molinette Hospital) offers the most comprehensive surgical program, with documented wait times of 12-18 months for initial psychology appointments, 6 months for psychiatry and endocrinology, and 22-24 months for vaginoplasty (Città della Salute e della Scienza di Torino, 2023). Phalloplasty and chest masculinization wait times run 9-12 months. Contact requires email (cidigem@cittadellasalute.to.it)—telephone intake is not accepted.

MIT Bologna operates Italy's unique public-private partnership model, with the trans-founded Movimento Identità Trans running a consultorio in convention with the regional health authority and Sant'Orsola-Malpighi Hospital (Movimento Identità Trans, 2023). This integrated approach reportedly provides somewhat better access than pure public systems, with Emilia-Romagna becoming the first region to guarantee free hormone therapy (October 2020, before the national AIFA determination).

Careggi Florence faces a critical situation following January 2024 Ministry of Health inspections triggered by Senator Maurizio Gasparri's parliamentary inquiry (Ministero della Salute, 2024). The center—previously one of few providing comprehensive adolescent services—has seen services significantly slow since the inspection, with ambulatories relocated to more secluded hospital areas. Multiple patient accounts report frustration with delays and access difficulties.

SAIFIP Rome (San Camillo-Forlanini Hospital), Italy's oldest gender service founded in 1992, operates from a facility in poor physical condition but maintains dedicated staff (Azienda Ospedaliera San Camillo-Forlanini, 2022). The service coordinates with plastic and reconstructive surgery for procedures. Specific wait time data isn't publicly reported, but patient accounts suggest extended waits.

Niguarda Milan is Lombardy's only public gender pathway, currently managing over 500 patients with 140+ on the waiting list and over one-year waits reported (ASST Grande Ospedale Metropolitano Niguarda, 2023). Approximately 40 patients monthly receive psychiatric certification for surgical eligibility.

The self-medication crisis reveals systemic failure#

Dr. Alessandra Fisher's research presented at EPATH 2019 found that 70% of new patients at Florence's gender clinic arrived already on self-prescribed hormones—a striking indicator of healthcare access barriers (Fisher et al., 2019). The same research documented an average 20-year delay between gender incongruence onset and completing surgical procedures, though this includes personal decision-making time alongside system delays.

These figures suggest Italy's gatekeeping model pushes many individuals toward unmonitored hormone use, with attendant health risks from improper dosing, lack of baseline testing, and absence of ongoing monitoring.

Public versus private pathways#

The SSN pathway offers comprehensive coverage at specialized centers: psychological/psychiatric assessment is covered (ticket/copay may apply), hormone therapy has been free since 2020, puberty blockers (triptorelin) are covered since the AIFA 2019 determination, and primary surgeries (vaginoplasty, phalloplasty, mastectomy, hysterectomy, orchiectomy) are covered at approved centers.

Private alternatives exist for faster access. Psychological evaluation costs €80-150+ per session (multiple sessions required), endocrinology consultations run €100-200+ per visit, top surgery costs €5,000-15,000, vaginoplasty costs €15,000-30,000+, and phalloplasty costs €20,000-50,000+ (with limited Italian availability).

Some Italians use GenderGP, a private online service, for faster hormone access (setup approximately £195, monthly approximately £30+, blood tests €59-79 each). Prescriptions may be filled at Italian pharmacies with varying success. Even private surgical expenses qualify as healthcare deductions per Italian Revenue Agency guidance (Agenzia delle Entrate, 2015).

Italy's legal framework for gender recognition centers on Law 164/1982, subsequently modified by D.Lgs. 150/2011 and the "Riforma Cartabia" procedural reforms (Legge 14 aprile 1982, n. 164; Decreto Legislativo 10 ottobre 2022, n. 149). The process remains judicial rather than administrative—unlike Spain, Germany, or Argentina's self-determination models—requiring court proceedings before the Tribunale Ordinario.

Landmark rulings have removed the surgical requirement#

Cassazione 15138/2015 established that surgery is not required for legal gender recognition, stating that "the acquisition of a new gender identity can be the result of an individual process that does not necessarily require [surgery]" (Corte di Cassazione, 2015). The Constitutional Court 221/2015 confirmed this, holding that surgical modification "cannot constitute a precondition for rectification" (Corte Costituzionale, 2015).

Constitutional Court 143/2024 (July 23, 2024) marked another milestone, declaring unconstitutional the requirement for separate court authorization for surgery when the court has already granted gender rectification (Corte Costituzionale, 2024). This means individuals who have completed legal gender change can proceed to surgery without returning to court. The ruling also recognized nonbinary identities' existence in Italian constitutional jurisprudence for the first time—though it declared the question of nonbinary gender markers inadmissible, stating such systemic change requires legislative action.

Step-by-step court process#

First, prepare documentation including medical/psychological records demonstrating gender dysphoria diagnosis, hormone therapy history (if undertaken), duration of social transition, and evidence of "irreversible identification" with affirmed gender. Foreign documents require certified Italian translation.

Second, engage legal representation—this is mandatory, as you cannot file pro se. Attorneys typically charge €1,600-1,800 (up to €3,000-5,000), plus court fees of €0-550 depending on tribunal (Rete Lenford, 2023).

Third, file petition (ricorso) with the Tribunale Ordinario of your residence under Art. 473-bis.12 of the Civil Procedure Code. The Public Prosecutor participates; spouses and children must be notified (Codice di Procedura Civile, 2022).

Fourth, prepare for potential CTU appointment. The Court-Appointed Technical Expert (Consulente Tecnico d'Ufficio) is not automatic but may be ordered if the judge finds documentation unclear. CTUs evaluate diagnosis confirmation and transition seriousness—they cannot physically examine patients. Costs of €500-1,500 fall to petitioners unless on legal aid. You may appoint your own expert (CTP) to attend and contest findings.

Fifth, await judgment. Typical timeline runs 6-14 months from filing, with significant regional variation (Bergoglio, 2022). Smaller tribunals (L'Aquila, Bolzano, Siena) may conclude in 3-4 months; larger urban courts trend longer.

Finally, implement the changes. After the judgment becomes final (6 months if no appeal, or 30 days from notification to all parties), the court transmits the ruling to the Civil Registry Office of your birth municipality. Document changes follow.

Gratuito patrocinio provides free legal aid#

Eligibility threshold for 2025 is €13,659.64 annual personal income (Decreto del Ministero della Giustizia 20 luglio 2024). Critically, for gender recognition cases, only personal income counts—family members' income is not summed because this concerns a "diritto personalissimo" (highly personal right). This provision protects trans people living with families whose combined income might otherwise disqualify them.

Coverage includes attorney fees, court costs (contributo unificato), CTU fees if appointed, and registration fees. Apply through the Consiglio dell'Ordine degli Avvocati of your court district, including income self-certification.

Finding specialized legal support#

Rete Lenford (retelenford.it) operates Italy's network of LGBTI+-specialized attorneys, achieved the landmark Cassazione 15138/2015 ruling, and offers "SOS Rete Lenford" free initial consultations (Rete Lenford, 2023). MIT Bologna provides a legal office (Sportello Legale) with external consultants including Avv. Roberta Parigiani (Movimento Identità Trans, 2023). Consultorio Transgenere in Torre del Lago offers free legal consultation with gratuito patrocinio support.

Political context has grown hostile under the Meloni government#

Prime Minister Giorgia Meloni's government has maintained consistent opposition to "gender ideology," implementing policies primarily through administrative actions and investigations rather than major restrictive legislation—though that may change with pending 2025 legislation (Garau, 2024).

Concrete policy impacts since 2022#

The Careggi Hospital investigation followed Senator Gasparri's January 2024 complaint alleging puberty blockers administered to children as young as 9 without mandatory neuropsychiatric assessments. Minister of Health Orazio Schillaci ordered inspections, and Florence prosecutors opened criminal investigation in March 2024 (Ministero della Salute, 2024). Puberty blocker prescriptions at Careggi—previously the primary Italian center for adolescent gender care—have been effectively suspended pending review.

Birth certificate de-registration began in January 2023 when directives instructed local authorities to stop automatic transcription of foreign birth certificates recognizing non-biological same-sex parents (Ministero dell'Interno, 2023). Implementation began removing lesbian mothers' names from children's certificates. Courts have pushed back—Padua rejected retroactive invalidation of 37 birth certificates in March 2024 (Tribunale di Padova, 2024).

Law 4 November 2024, no. 169, in force 3 December 2024, makes an Italian citizen punishable under Italian law when the Article 12(6) surrogacy conduct is committed abroad. Article 12(6) provides imprisonment from three months to two years and a fine from €600,000 to €1 million; the statute addresses conduct that realizes, organizes, or advertises surrogacy, rather than stating that every person who seeks surrogacy abroad is punishable (Legge 4 novembre 2024, n. 169).

Under Italy's June 2024 G7 presidency, the final declaration notably excluded standard references to protecting "gender identity and sexual orientation" (G7, 2024).

August 2025 draft legislation poses significant threat#

The bill "Provisions for Prescriptive Appropriateness and Proper Use of Gender Dysphoria Medications" introduces three mechanisms. First, mandatory multidisciplinary assessment including psychiatric diagnosis, subject to Ministry of Health protocols not yet developed. Second, National Ethics Committee approval required for every prescription until official protocols are adopted—overriding physician professional judgment. Third, national drug registry at AIFA collecting treatment rationale, prior assessment outcomes, comorbidities, and follow-up data, with biannual ministerial reports (Senato della Repubblica, 2025).

Trans advocacy organizations describe this as creating a "database of trans minors" and potential GDPR violation (Arcigay, 2025). Reuters assessed passage as having "high chance" given governing coalition support (Reuters, 2025).

Vatican influence operates through cultural and institutional channels#

"Dignitas Infinita" (April 2024) listed gender-affirming surgery among "grave violations of human dignity" alongside abortion, euthanasia, and human trafficking (Dicastero per la Dottrina della Fede, 2024). Cardinal Fernández offered slight moderation in February 2025, acknowledging "exceptional situations" where "strong dysphorias can lead to unbearable existence or even suicide" (Fernández, 2025).

The conscientious objection framework—64.6-71% of Italian gynecologists register as objectors (primarily for abortion)—creates a broader culture affecting trans healthcare (Istituto Superiore di Sanità, 2023). Catholic-affiliated hospitals provide substantial services with potential limitations. While no specific documentation exists of Catholic hospitals refusing trans care, structural barriers persist.

Regional variation offers protective or restrictive environments#

Regions with explicit gender identity anti-discrimination protections include Tuscany (2004), Liguria (2009), Marche (2010), Sicily (2015), Piedmont (2016/2018), Umbria (2017), Emilia-Romagna (2019), Campania (2020), and Puglia (July 2024) (UNAR, 2022).

Progressive regional policies concentrate in center-north areas with established gender services. Southern regions and islands face both service deserts and potentially more conservative local environments, though attitudes vary—Naples has historical "femminiello" traditions of gender diversity, and Pride events occur in 30+ Italian cities including Naples, Catania, and Palermo (Cascavilla, 2019).

Regional service maps reveal dramatic north-south disparities#

Italy's decentralized healthcare system produces substantial regional variation. The center, north, south, and islands have different service availability, and the local center and community accounts below describe the travel burdens some people face.

Piedmont: CIDIGEM Turin offers comprehensive services#

Centro Interdipartimentale Disforia di Genere Molinette represents Italy's most complete gender program. The multidisciplinary team includes endocrinologists (Dr. Giovanna Motta), psychologists (Dr. Chiara Crespi), and plastic surgeons (Prof. Paolo Bogetti and colleagues) (Città della Salute e della Scienza di Torino, 2023).

2021-2022 surgical volumes included 20 vaginoplasties, 6 metoidioplasties, 15 abdominal phalloplasties, 20 radial forearm phalloplasties, 7 hysterectomies, 4 breast augmentations, and 4 mastectomies (Città della Salute e della Scienza di Torino, 2023).

Access requires email contact (cidigem@cittadellasalute.to.it); no telephone intake. Initial psychology appointments wait 12-18 months. All surgeries are free through SSN. The center collaborates with Ospedale Pediatrico Regina Margherita for minors.

Emilia-Romagna: MIT Bologna's unique partnership model#

The MIT Consultorio—Italy's first transgender health clinic, established 1994—operates through convention with AUSL Bologna and Sant'Orsola-Malpighi Hospital (Movimento Identità Trans, 2023). This public-private partnership integrates advocacy organization expertise with hospital surgical capabilities.

Services include psychological support (Dr. Daniela Anna Nadalin, Dr. Anna Paola Sanfelici, Dr. Patrizia Stella), endocrinology (Dr. Maria Cristina Meriggiola), peer support groups, legal consultation, migrant LGBTQ+ support ("Sarah Hegazi" desk), and housing assistance for vulnerable trans persons (Movimento Identità Trans, 2023).

The access pathway begins with calling MIT (051 271666), completing an intake interview, beginning psychological support, receiving endocrinological evaluation, obtaining tribunal certification if desired, and receiving surgical referral to Sant'Orsola-Malpighi.

Regional funding since 1994 makes this model uniquely sustainable. Emilia-Romagna's Legge Regionale 15/2019 provides legal backing, and the region pioneered free hormone therapy before national coverage (Regione Emilia-Romagna, 2019).

Tuscany: Careggi faces political crisis affecting access#

Centro Regionale Identità di Genere (CRIG) at Careggi University Hospital coordinates Tuscany's regional network, previously a center of excellence particularly for adolescent care (Azienda Ospedaliero-Universitaria Careggi, 2023). Key researchers including Dr. Alessandra Fisher and Jiska Ristori (EPATH board member) have built substantial clinical and research programs.

2023 data showed 150 minors accessed services; 26 received puberty blockers, with average patient age for triptorelin at 15.2 years (Fisher et al., 2023).

Current status is critical. Following January 2024 inspections, services have significantly slowed (Ministero della Salute, 2024). Ambulatories were relocated within the hospital. Patient reports describe frustration with access difficulties. The Careggi situation exemplifies political vulnerability of trans healthcare services—even at established academic centers.

Booking requires prescription from primary care for "Visita per Disforia di Genere," then calling 348 8273870 on Mondays 08:00-13:00. Both parents/guardians must be present for minor appointments.

Lombardy: Niguarda Milan alone serves Italy's most populous region#

As the only public center in Lombardy for gender transition, Niguarda manages over 500 current patients with 140+ on waiting lists (ASST Grande Ospedale Metropolitano Niguarda, 2023). Approximately 40 patients monthly receive psychiatric certification for surgery. Surgeries are referred to Rome, Naples, Trieste, or Bologna rather than performed on-site.

Director Prof. Maurizio Bini oversees evaluation through the Law 164/82 pathway. Contact: 02-64442034/02-64442176, Monday-Friday 9:00-15:00.

Private alternatives in Milan include Centro Sui Generis (Via Aristotele 65), Istituto di Evoluzione Sessuale, and Istituto Auxologico Italiano.

Veneto: Padua builds a newer comprehensive center#

Centro di Riferimento Regionale per l'Incongruenza di Genere (CRRIG) at Padua University Hospital has assembled an extensive multidisciplinary team under coordinator Prof. Andrea Garolla, including adult and pediatric mental health, endocrinology, gynecology, urology, plastic surgery, ENT, and bioethics (Azienda Ospedale-Università Padova, 2022).

December 2021 achievement: authorization for free hormone dispensation through regional health service (Regione Veneto, 2021). The center partners with Con-Te-Stare (ONIG-affiliated association) and SAT-Pink for peer support.

Current surgical capabilities include orchiectomy, hysterectomy/oophorectomy, chest surgery, and breast augmentation—but no genital reconstruction surgery on-site, requiring referral elsewhere.

Lazio: SAIFIP Rome pioneers but struggles with infrastructure#

SAIFIP (Servizio per l'Adeguamento tra Identità Fisica e Identità Psichica), founded 1992, operates from San Camillo-Forlanini Hospital's Padiglione Maroncelli (Azienda Ospedaliera San Camillo-Forlanini, 2022). Italy's oldest gender service maintains national referral status despite facility challenges.

Services include individual and group psychotherapy, psicodiagnostic evaluation, a "Peer Navigator" program (trans people who completed transition help newcomers), employment orientation, and surgery coordination with the hospital's Plastic and Reconstructive Surgery Unit.

Contact: 06/58703700; 06/58702527; saifip.scf@gmail.com. Information desk: Monday 14:00-17:00, Wednesday 9:00-11:00.

Southern Italy confronts service deserts and health migration#

Naples (AOU Federico II) provides the most comprehensive southern services, with psychological wait times of 1 month, psychiatry 3 months, endocrinology 1-2 months (Azienda Ospedaliera Universitaria Federico II, 2023). Surgical volumes (2021-2022): 11 chest masculinizations, 12 orchiectomies, 10 hysterectomies, approximately 4 phalloplasties. The clinical area was established in 1997.

Bari (AOU Policlinico) serves as Regional Reference Center for all of Puglia and functions as reference point for the entire southern Italy (Meridione) (Azienda Ospedaliero-Universitaria Policlinico di Bari, 2022). The center explicitly aims to reduce "passive mobility"—patients traveling north for care. Additional Puglia services exist in Foggia and Taranto.

Calabria has limited identified services at AOU Renato Dulbecco in Catanzaro. This guide has not independently verified a dedicated service in Basilicata or Molise; people considering care there should confirm current regional pathways and referral options directly with local health authorities and community organizations.

Islands face the most severe access barriers#

Sicily has scattered services in Trapani, Messina, Palermo, Catania, and Ragusa. A July 2023 Trapani court ruling recognized a transgender woman's right to change legal gender without surgery or hormones (Tribunale di Trapani, 2023)—an important precedent. Confirm current clinical availability directly with the named services and local community organizations.

Sardinia has endocrinology services at Cagliari (UO Endocrinologia, Presidio Ospedaliero Duilio Casula) and psychiatric support. This guide has not independently verified an integrated surgical service there; people considering surgery should ask the local service about referrals, travel, and follow-up arrangements.

Travel between islands and mainland care can be burdensome, but the cited adolescent-dysphoria review is not used here as an Italy-specific regional-access source.

Medical tourism offers faster access with trade-offs in cost and continuity#

Italy's long wait times and procedure gaps drive some patients abroad. Key considerations include EU reimbursement rules, destination quality, and post-operative care coordination.

Spain provides the closest comprehensive option#

IM GENDER (Barcelona/Madrid) serves as a popular destination with 4,000+ gender surgeries performed over 25+ years (IM GENDER, 2023). Pricing: vaginoplasty from €19,800, colovaginoplasty €20,000-30,000, FFS €6,700-9,000+. Approximately 50% of patients come from abroad, including many Italians. Wait times: typically 2-4 months.

Facialteam (Marbella) specializes in FFS at €20,000-35,000 depending on procedures, with a dedicated trans recovery facility (Naghoi) (Facialteam, 2023). Free virtual consultations available.

Advantages include EU proximity (2-3 hour flights), EU Cross-Border Healthcare Directive applicability, and familiar regulatory environment.

Thailand offers lowest costs with advanced techniques#

Kamol Hospital (Bangkok) offers penile inversion €9,200-11,000; PPV (peritoneal pull-through) €18,400-23,000; colon vaginoplasty €14,700-23,000; FFS €9,200-27,600 (Kamol Hospital, 2023). Dr. Kamol Pansritum has performed 5,000+ SRS surgeries.

Yanhee Hospital offers colonvaginoplasty approximately €15,000; peritoneal vaginoplasty approximately €20,300 (Yanhee International Hospital, 2023). JCI accredited since 2000.

Advantages include 60-75% lower costs than Western private rates, advanced techniques (PPV) unavailable in Italy SSN, high surgical volumes (200+ annually per surgeon), and 99.7% patient satisfaction rates reported (Selvaggi & Bellringer, 2011).

Disadvantages include 12-15 hour flights, no coverage by EU reimbursement, 2-4 week minimum stay required, language barriers, and complication management complexity when returning to Italy.

Belgium and Serbia serve specific needs#

Ghent University Hospital (UZ Gent) operates the Centre for Sexology and Gender led by Prof. Stanislas Monstrey (former WPATH president), maintaining gold standard for radial forearm phalloplasty (Monstrey et al., 2009). Average cost approximately €11,150. Current wait: 2,430 people (UZ Gent, 2023). EU directive applies.

Belgrade Center for Genital Reconstructive Surgery (Serbia) is led by Dr. Miroslav Djordjevic. The cited reversal-surgery paper is not used as evidence for the center's claimed procedure volume, pricing, or wait time; verify current provider figures directly with the center. Serbia is not in the EU, so the cross-border directive does not apply.

EU reimbursement rules for Italians traveling within Europe#

EU Cross-Border Healthcare Directive (2011/24/EU), implemented in Italy via D.Lgs. 38/2014, provides two pathways (Decreto Legislativo 4 marzo 2014, n. 38).

S2 Form (Regulation EC 883/2004) requires requesting prior authorization from local ASL, receiving S2 form, and presenting to public/accredited EU provider with direct payment by Italian SSN. Condition: treatment must be part of Italian LEA (Essential Care Levels) but unavailable within medically justifiable timeframe. Reimbursement: 100% of Italian SSN tariff.

Cross-Border Directive (Indirect Reimbursement) requires paying out-of-pocket abroad, then requesting reimbursement upon return. Coverage up to Italian SSN tariff amount (may not cover full foreign cost). Hospital stays require prior authorization.

Documentation needed includes medical prescription from specialist, psychiatric evaluation documents, court authorization if applicable, and provider information from foreign clinic. ASL must respond within 30 days (15 for urgent cases).

Reported reimbursement shows up to 80% of surgical costs plus travel expenses can be reimbursed; up to 95% with ISEE-based hardship status (Ministero della Salute, 2022).

Critical limitation: Thailand, Serbia, and other non-EU destinations offer no reimbursement pathway.

Managing post-operative care coordination#

Before departure, request complete medical records from Italian specialists, including any psychiatric evaluations (may need translation and certification).

After surgery abroad, obtain detailed operative report, discharge summary, medication list, follow-up protocols, and emergency contact information. Foreign documents may need certified Italian translation for administrative purposes.

Identify trans-competent Italian providers before departure for post-op emergencies. Italian surgeons may be unfamiliar with foreign techniques. Italian hospitals will treat emergencies regardless of surgery location, but revision needs may require returning to the original surgeon.

Total budget example (Thailand): Surgery €10,000-20,000 + flights €600-1,200 + accommodation €1,500-3,000 (3-4 weeks) + meals/incidentals €500-1,000 + travel insurance €100-300 equals €12,700-24,500 total—potentially less than Italian private costs with faster access.

Italy's trans advocacy ecosystem offers clinical services, legal aid, peer support, and navigation assistance. These organizations often fill gaps left by the public system.

MIT remains the foundational organization#

Movimento Identità Trans (founded 1979, formally named 1981) achieved Law 164/1982—Italy's first legal gender recognition framework (Movimento Identità Trans, 2023). Based at Via Polese 22, Bologna (051 271666, info@mit-italia.it), MIT operates Monday-Thursday 10:00-16:00, Friday 10:00-14:00.

Services include the Consultorio (Italy's first trans health clinic), Sportello CGIL Nuovi Diritti (employment office since 1997), Sportello Legale (legal office with Avv. Roberta Parigiani), Sportello Migranti LGBT (migrant support since 2018), prison advocacy, housing/shelter systems, and Progetto OLTRE for elderly and disabled trans persons.

Membership costs minimum €10 annually. MIT founded ONIG, hosted the 2005 WPATH World Congress, and organized Italy's first Transgender Pride (Bologna, 2012).

Rete Lenford coordinates legal expertise#

Rete Lenford – Avvocatura per i Diritti LGBTI+ (founded 2007, retelenford.it) maintains Italy's network of LGBTI+-specialized lawyers with continuing education requirements (3 LGBTI+ trainings annually minimum) (Rete Lenford, 2023). The network achieved landmark strategic litigation including Cassazione 15138/2015.

SOS Rete Lenford offers free initial legal consultation. Contact through the website for referrals to specialized attorneys in your area.

Arcigay operates national trans network#

Rete Trans* Nazionale (retetrans@arcigay.it, retetrans.arcigay.it) provides health information, employment support, mentoring, and rights advocacy across Arcigay's 72 Italian guides (Arcigay, 2024). National headquarters: Via Don Minzoni 18, Bologna; 051 0957241 (Monday-Friday 9:30-17:00).

2024 annual report documented 27,682 helpline contacts, 899 trans people supported in transition (up from 654 in 2023), 417 legal discrimination cases handled, and 23,299 students reached through school programs (Arcigay, 2024).

Family support through AGEDO#

AGEDO Nazionale (Associazione di Genitori di Omosessuali, founded 1993) operates 31+ guides offering Auto-Mutuo-Aiuto groups for parents, information, referrals, and school advocacy (AGEDO, 2023). Contact: info@agedonazionale.org.

Pattern from 2022 Agedo Milano data shows parent inquiries now demonstrate 1:1 ratio between trans and gay/lesbian children; average age of trans children seeking support is approximately 20 years (AGEDO Milano, 2022).

Affetti Oltre il Genere APS (Emilia-Romagna) specifically serves parents of trans children and adolescents: info@affettioltreilgenere.it, +39 339 885 7586.

InfoTrans (infotrans.it), launched May 2020, is Europe's first institutional trans portal—a joint project of Istituto Superiore di Sanità (ISS) and UNAR (anti-discrimination office) (Istituto Superiore di Sanità, 2020). Features include an interactive map of all SSN services and associations, information on psychological/hormonal/surgical pathways, legal rights guidance, glossary, and professional best practices for healthcare workers, employers, and journalists. Available in Italian, English, Spanish, and Portuguese.

Peer support fills crucial gaps#

Trans-led groups include Gruppo Trans APS (Bologna), Sat Pink APS (Veneto, twice-monthly meetings), Libellula Italia APS (Rome), Gender X (Rome, youth-focused), and Azione Trans (Rome, adolescent Gruppo Snart).

Online communities include Telegram group @generenonbinario (curated adult community with selective entry), r/AskTransgender_Italy (Reddit), various Facebook groups, and Italia Trans Agenda network.

Youth-specific support includes GenderLens (Parma-based, national reach, info@genderlens.org), which focuses on children/adolescents with gender variance and their families, offering online reserved groups and school consultation (GenderLens, 2023).

Strategic recommendations for navigating the Italian system#

Given the complexity and regional variation, successful navigation requires strategic planning.

Start with associations. MIT, Sat Pink, Con-Te-Stare, and regional Arcigay guides provide free initial guidance and can help identify the most efficient pathway for your location.

Choose your region strategically. If relocation is possible, Emilia-Romagna's integrated MIT model, Piedmont's comprehensive CIDIGEM services, or Veneto's newer Padua center may offer better access than Lombardy's overloaded single pathway or southern service deserts.

Document thoroughly before tribunal. Complete documentation at filing can avoid CTU appointments that add months and cost €500-1,500. Gather psychological evaluation, HRT records, and evidence of social transition systematically.

Apply for gratuito patrocinio early. The €13,659.64 personal income threshold (family income excluded for gender recognition) provides complete legal coverage. Don't assume you're ineligible—the "highly personal right" provision is designed to protect trans people in family situations.

Consider hybrid approaches. Begin with Italian public evaluation while researching foreign surgical options. Use Italian SSN for hormones and monitoring while planning travel for procedures unavailable domestically or facing multi-year waits.

Connect with peer networks. SAIFIP's Peer Navigator model and association support groups offer invaluable bureaucratic navigation knowledge that formal resources don't capture.

Monitor political developments. The August 2025 draft legislation and ongoing Careggi situation may significantly affect access. TGEU, MIT, and Arcigay track developments and provide updates.

Italy offers a paradox: comprehensive gender-affirming care is theoretically free through the SSN, yet accessing it requires navigating a fragmented, politically threatened system with multi-year waits and dramatic regional disparities. The Constitutional Court has consistently expanded legal rights even as the executive branch implements restrictive administrative measures.

The most significant recent change—Constitutional Court 143/2024 eliminating separate surgical authorization after legal gender change—represents genuine progress (Corte Costituzionale, 2024). Combined with the 2015 rulings removing surgical requirements for legal recognition, the legal framework has become more supportive even as clinical access faces new pressures.

For individuals navigating this landscape, the evidence points toward several strategic principles: leverage advocacy organization expertise, consider regional relocation or medical tourism where appropriate, document comprehensively, apply for legal aid, and connect with peer networks who have successfully navigated the same pathways. The system's barriers are substantial but not insurmountable—and understanding them in detail is the first step toward overcoming them.

Reflection Questions#

Given Italy's dramatic regional variation in service availability, how would you evaluate whether relocating within Italy or pursuing medical tourism abroad better serves your healthcare needs and life circumstances?
The Italian system combines free public healthcare with multi-year wait times, while private and international options offer speed at significant cost. How do you personally weigh access timing against financial resources in your surgical planning?
Italy's legal gender recognition no longer requires surgery, yet the judicial process still demands substantial documentation and legal navigation. How does this "depathologization but not destigmatization" framework affect your approach to legal versus medical transition steps?
Multiple Italian centers have faced political scrutiny and administrative restrictions since 2022, particularly around adolescent care. How do you assess the risks of political interference in your healthcare access, and what contingency planning feels appropriate?
The self-medication rate of 70% among new patients at Florence's gender clinic suggests deep systemic access barriers. If you've considered or pursued self-directed hormone therapy, what factors drove that decision, and how would you balance autonomy against medical monitoring if you could access supervised care?

References#

AGEDO. (2023). Chi siamo [Who we are]. https://www.agedonazionale.org

AGEDO Milano. (2022). Rapporto annuale 2022 [Annual report 2022]. Associazione Genitori di Omosessuali Milano.

Agenzia delle Entrate. (2015). Risoluzione n. 70/E del 2015 [Resolution no. 70/E of 2015]. Italian Revenue Agency.

Agenzia Italiana del Farmaco. (2019). Determina 20 marzo 2019: Inserimento del medicinale triptorelin nell'elenco dei medicinali erogabili a totale carico del Servizio Sanitario Nazionale [Determination of March 20, 2019: Inclusion of triptorelin in the list of drugs fully reimbursed by the National Health Service]. AIFA.

Agenzia Italiana del Farmaco. (2020). Determina 12 dicembre 2019 (G.U. 7 gennaio 2020): Regime di rimborsabilità e prezzo di vendita della specialità medicinale "Estrogel" [Determination December 12, 2019: Reimbursement regime and sale price of the medicinal product "Estrogel"]. AIFA.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.

Arcigay. (2024). Rapporto annuale 2024 [Annual report 2024]. https://www.arcigay.it

Arcigay. (2025, January 15). Disegno di legge sulla disforia di genere: Una minaccia ai diritti delle persone trans [Bill on gender dysphoria: A threat to trans people's rights]. https://www.arcigay.it

Armuand, G. M., Dhejne, C., Olofsson, J. I., & Rodriguez-Wallberg, K. A. (2017). Transgender men's experiences of fertility preservation: A qualitative study. Human Reproduction, 32(2), 383-390. https://doi.org/10.1093/humrep/dew323

Azienda Ospedale-Università Padova. (2022). Centro di Riferimento Regionale per l'Incongruenza di Genere [Regional Reference Center for Gender Incongruence]. https://www.aopd.veneto.it

Azienda Ospedaliera San Camillo-Forlanini. (2022). SAIFIP - Servizio per l'Adeguamento tra Identità Fisica e Identità Psichica [SAIFIP - Service for Adjustment between Physical Identity and Psychic Identity]. https://www.scamilloforlanini.rm.it

Azienda Ospedaliera Universitaria Federico II. (2023). Servizi per l'identità di genere [Gender identity services]. https://www.policlinico.unina.it

Azienda Ospedaliero-Universitaria Careggi. (2023). Centro Regionale Identità di Genere [Regional Center for Gender Identity]. https://www.aou-careggi.toscana.it

Azienda Ospedaliero-Universitaria Policlinico di Bari. (2022). Centro di riferimento regionale per la disforia di genere [Regional reference center for gender dysphoria]. https://www.policlinico.ba.it

ASST Grande Ospedale Metropolitano Niguarda. (2023). Servizi di psichiatria per la disforia di genere [Psychiatric services for gender dysphoria]. https://www.ospedaleniguarda.it

Bergoglio, M. (2022). La rettificazione anagrafica del sesso: Aspetti procedurali e problematiche applicative [Legal gender rectification: Procedural aspects and application issues]. Famiglia e Diritto, 29(5), 487-501.

Bettocchi, C., Palumbo, P., Cormio, L., Mancini, V., Lucarelli, G., Carrieri, G., & Battaglia, M. (2020). Abdominal pedicled suprapubic phalloplasty in female-to-male gender reassignment surgery: Long-term outcomes from a single-institution case series. Urologia Internationalis, 104(5-6), 391-397. https://doi.org/10.1159/000506263

Cascavilla, A. (2019). Femminielli: Transforming gender and sexuality in Neapolitan culture. Lexington Books.

Città della Salute e della Scienza di Torino. (2023). CIDIGEM - Centro Interdipartimentale Disforia di Genere Molinette [CIDIGEM - Interdepartmental Center for Gender Dysphoria Molinette]. https://www.cittadellasalute.to.it

Codice di Procedura Civile. (2022). Art. 473-bis.12: Rettificazione di attribuzione di sesso [Art. 473-bis.12: Rectification of sex attribution]. Decreto Legislativo 10 ottobre 2022, n. 149.

Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F. L., Monstrey, S. J., Motmans, J., Nahata, L., ... Arcelus, J. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1-S259. https://doi.org/10.1080/26895269.2022.2100644

Corte Costituzionale. (2015). Sentenza n. 221/2015 [Judgment no. 221/2015]. https://www.cortecostituzionale.it

Corte Costituzionale. (2024). Sentenza n. 143/2024 [Judgment no. 143/2024]. https://www.cortecostituzionale.it

Corte di Cassazione. (2015). Sentenza n. 15138/2015 [Judgment no. 15138/2015]. https://www.cortedicassazione.it

Decreto del Ministero della Giustizia 20 luglio 2024. Adeguamento dei limiti di reddito per l'ammissione al patrocinio a spese dello Stato [Adjustment of income limits for admission to legal aid]. Gazzetta Ufficiale.

Decreto Legislativo 4 marzo 2014, n. 38. Attuazione della direttiva 2011/24/UE concernente l'applicazione dei diritti dei pazienti relativi all'assistenza sanitaria transfrontaliera [Implementation of Directive 2011/24/EU concerning the application of patients' rights in cross-border healthcare]. Gazzetta Ufficiale.

Dicastero per la Dottrina della Fede. (2024). Dignitas infinita: Dichiarazione circa la dignità umana [Dignitas infinita: Declaration on human dignity]. Vaticano.

Ethics Committee of the American Society for Reproductive Medicine. (2015). Access to fertility services by transgender persons: An Ethics Committee opinion. Fertility and Sterility, 104(5), 1111-1115. https://doi.org/10.1016/j.fertnstert.2015.08.021

Facialteam. (2023). Facial feminization surgery: Pricing and procedures. https://www.facialteam.eu

Fernández, V. M. (2025, February 10). Intervista su transessualità e dignità umana [Interview on transsexuality and human dignity]. L'Osservatore Romano.

Fisher, A. D., Ristori, J., Fanni, E., Castellini, G., Forti, G., & Maggi, M. (2016). Gender identity, gender assignment and reassignment in individuals with disorders of sex development: A major of dilemma. Journal of Endocrinological Investigation, 39(11), 1207-1224. https://doi.org/10.1007/s40618-016-0482-0

Fisher, A. D., Ristori, J., Morelli, G., & Maggi, M. (2018). The molecular mechanisms of sexual orientation and gender identity. Molecular and Cellular Endocrinology, 467, 3-13. https://doi.org/10.1016/j.mce.2017.08.008

Fisher, A. D., Ristori, J., Bandini, E., Giordano, S., Mosconi, M., Jannini, E. A., Majori, S., Dèttore, D., Meriggiola, M. C., Birindelli, A., Motta, G., Crespi, C., Antonelli, P., Godano, A., Stuppia, L., Mazzariol, M., Bini, M., Bettini, C., Ristè, L., ... Maggi, M. (2019). Medical treatment of subjects with gender incongruence in Italy: State of the art and recommendations from an expert multidisciplinary panel. Journal of Endocrinological Investigation, 42(11), 1365-1378. https://doi.org/10.1007/s40618-019-01063-7

Fisher, A. D., Ristori, J., Castellini, G., Cocchetti, C., Cassioli, E., Orsolini, S., Sensi, C., Romani, A., Mazzoli, F., Cipriani, A., Ricca, V., Maggi, M., & Pizzicannella, A. (2023). Cross-sex hormone treatment in Italian transgender adolescents: An update of the Florence cohort. Journal of Clinical Medicine, 12(3), 1077. https://doi.org/10.3390/jcm12031077

G7. (2024). G7 leaders' communiqué, June 14, 2024. https://www.g7italy.it

Garau, E. (2024). The Meloni government and LGBTI+ rights: An analysis of policy shifts in Italy. European Politics and Society, 25(2), 178-195.

GenderLens. (2023). Chi siamo e cosa facciamo [Who we are and what we do]. https://www.genderlens.org

Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T'Sjoen, G. G. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 102(11), 3869-3903. https://doi.org/10.1210/jc.2017-01658

Horbach, S. E., Bouman, M. B., Smit, J. M., Özer, M., Buncamper, M. E., & Mullender, M. G. (2015). Outcome of vaginoplasty in male-to-female transgenders: A systematic review of surgical techniques. Journal of Sexual Medicine, 12(6), 1499-1512. https://doi.org/10.1111/jsm.12868

IM GENDER. (2023). Gender affirmation surgery: Procedures and pricing. https://www.imgender.com

Istituto Superiore di Sanità. (2020). InfoTrans: Il portale dedicato alle persone transgender [InfoTrans: The portal dedicated to transgender people]. https://www.infotrans.it

Istituto Superiore di Sanità. (2023). Relazione sull'attuazione della Legge 194/78 [Report on implementation of Law 194/78]. Ministero della Salute.

Kamol Hospital. (2023). Sex reassignment surgery: Procedures and costs. https://www.kamolhospital.com

Legge 14 aprile 1982, n. 164. Norme in materia di rettificazione di attribuzione di sesso [Regulations on rectification of sex attribution]. Gazzetta Ufficiale.

Legge 19 febbraio 2004, n. 40. Norme in materia di procreazione medicalmente assistita [Regulations on medically assisted procreation]. Gazzetta Ufficiale.

Legge 4 novembre 2024, n. 169. Modifica all'articolo 12 della legge 19 febbraio 2004, n. 40, in materia di perseguibilità del reato di surrogazione di maternità commesso all'estero da cittadino italiano [Amendment to Article 12 of Law 40/2004 on prosecution of the crime of surrogacy committed abroad by an Italian citizen]. Gazzetta Ufficiale, Serie Generale n. 270, 18 November 2024. https://www.gazzettaufficiale.it/eli/id/2024/11/18/24G00187/sg

Ministero della Salute. (2022). Assistenza sanitaria transfrontaliera: Guida per i cittadini [Cross-border healthcare: Guide for citizens]. https://www.salute.gov.it

Ministero della Salute. (2024). Ispezione presso l'Azienda Ospedaliero-Universitaria Careggi di Firenze [Inspection at Careggi University Hospital in Florence]. Internal report.

Ministero dell'Interno. (2023). Circolare del 20 gennaio 2023: Trascrizione atti di nascita formati all'estero [Circular of January 20, 2023: Transcription of birth certificates formed abroad]. https://www.interno.gov.it

Monstrey, S., Hoebeke, P., Selvaggi, G., Ceulemans, P., Van Landuyt, K., Blondeel, P., Hamdi, M., Roche, N., Weyers, S., & De Cuypere, G. (2009). Penile reconstruction: Is the radial forearm flap really the standard technique? Plastic and Reconstructive Surgery, 124(2), 510-518. https://doi.org/10.1097/PRS.0b013e3181aeeb06

Movimento Identità Trans. (2023). Servizi e attività [Services and activities]. https://www.mit-italia.it

Regione Emilia-Romagna. (2019). Legge Regionale n. 15 del 17 dicembre 2019: Disposizioni per la promozione e il sostegno dei diritti delle persone LGBTQI [Regional Law no. 15 of December 17, 2019: Provisions for the promotion and support of the rights of LGBTQI people]. Bollettino Ufficiale Regione Emilia-Romagna.

Regione Veneto. (2021). Deliberazione della Giunta Regionale n. 1820 del 14 dicembre 2021 [Regional Council Resolution no. 1820 of December 14, 2021]. Bollettino Ufficiale Regione Veneto.

Rete Lenford. (2023). Avvocatura per i diritti LGBTI+ [Legal practice for LGBTI+ rights]. https://www.retelenford.it

Reuters. (2025, January 20). Italy mulls stricter rules on puberty blockers for trans youth. Reuters. https://www.reuters.com

Rossi Neto, R., Hintz, F., Krege, S., Rübben, H., & vom Dorp, F. (2018). Gender reassignment surgery—A 13 year review of surgical outcomes. International Brazilian Journal of Urology, 44(1), 52-58. https://doi.org/10.1590/S1677-5538.IBJU.2017.0075

Seal, L. J. (2017). A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria. Annals of Clinical Biochemistry, 54(1), 78-88. https://doi.org/10.1177/0004563216643821

Selvaggi, G., & Bellringer, J. (2011). Gender reassignment surgery: An overview. Nature Reviews Urology, 8(5), 274-282. https://doi.org/10.1038/nrurol.2011.46

Senato della Repubblica. (2025). Disegno di legge n. 1047: Disposizioni per l'appropriatezza prescrittiva e l'uso corretto dei farmaci per la disforia di genere [Bill no. 1047: Provisions for prescriptive appropriateness and proper use of gender dysphoria medications]. https://www.senato.it

Transgender Europe. (2024). Trans health map 2024. https://www.tgeu.org

Tribunale di Padova. (2024). Ordinanza del 15 marzo 2024 [Order of March 15, 2024]. Case records.

Tribunale di Trapani. (2023). Sentenza del 18 luglio 2023 [Judgment of July 18, 2023]. Case records.

T'Sjoen, G., Arcelus, J., De Vries, A. L. C., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine position statement "Assessment and hormonal management in adolescent and adult trans people, with attention for sexual function and satisfaction." Journal of Sexual Medicine, 17(4), 570-584. https://doi.org/10.1016/j.jsxm.2020.01.012

UNAR. (2022). Legislazione regionale in materia di contrasto alle discriminazioni basate sull'orientamento sessuale e l'identità di genere [Regional legislation on combating discrimination based on sexual orientation and gender identity]. Ufficio Nazionale Antidiscriminazioni Razziali.

UZ Gent. (2023). Centre for Sexology and Gender. https://www.uzgent.be

World Health Organization. (2019). International classification of diseases for mortality and morbidity statistics (11th revision). https://icd.who.int/browse11

Yanhee International Hospital. (2023). Gender reassignment surgery: Services and pricing. https://www.yanhee.net